John P. Boehmer et al. JCHF 2017;5:

Slides:

Advertisements

Similar presentations

New 2011 SHIFT quality of life substudy Quality of life ( QoL) in heart failure: where do we stand? Therapies that have survival benefits either have a.

Advertisements

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.

ANNOUNCEMENTS. EVENTS CALENDAR TITLE OF EVENT Details about the event. Date: Month, Day Time: 00:00-00:00 Location: Campus Building.

Copyright © American Speech-Language-Hearing Association

Discontinuation of medication after nonfatal event: MI

Average histograms of hemoglobin oxygen saturation in the control and ischemic footpads show the distribution of hemoglobin saturation over all pixels.

Figure 1. Serum creatinine trend in the patient

Design of a multicohort evaluation of statin adherence after the start of 2 cost-sharing policies Sebastian Schneeweiss, et al. Circulation 2007;115:

Comparisons of “even” mock communities (a) and “staggered” mock communities (b) sequenced by MiSeqPE300 and HiSeqPE250. Comparisons of “even” mock communities.

Daniel J. Lenihan et al. BTS 2016;1:

In vivo selectivity of compound 6b.

Trial profile John A Dormandy et al. Lancet 2005;366:

Changes in archaeal diversity during great ape diversification.

Daniel J. Lenihan et al. BTS 2016;1:

Belinda Gray et al. JCHF 2013;1:

Matias J. Ison, Rodrigo Quian Quiroga, Itzhak Fried Neuron

Primary end point in normotensive and hypertensive patients at baseline (events per 100 patient-years of follow-up) Primary end point Nifedipine Placebo.

Line graph showing change in size over time relative to baseline CT

CHAMPION Trial design: Patients with recent hospitalization for heart failure were implanted with a pulmonary artery pressure monitor and randomized so.

G. Michael Felker et al. JCHF 2014;2:

Ethan S. Bromberg-Martin, Masayuki Matsumoto, Okihide Hikosaka Neuron

Ivan C. Gerling et al. JCHF 2013;1:

Anna Björkenheim et al. JACEP 2017;j.jacep

Jennifer T. Thibodeau et al. JCHF 2014;2:24-31

Anna Björkenheim et al. JACEP 2017;j.jacep

Peter E. Carson et al. JCHF 2015;3:

Mean (±95%CI) choice reaction time on the Scan package at baseline, at the end of treatment and 6 months after the end of treatment in patients with cirrhosis.

Rene L. Begay et al. JACEP 2018;4:

(A and B) Changes in the apnoea hypopnoea index (AHI) and 3% oxygen desaturation index (ODI) from baseline to treatment titration and 3 months of therapy:

Rami Doukky et al. JCHF 2016;4:24-35

Comparison of CMR and echocardiography in aortic regurgitation.

Maneesh Sud et al. JCHF 2017;5:

Patients’ most feared AEs reported to be intolerable when lasting more than 7 days at baseline, on study and at study completion (% patients); (A) grade.

John Rickard et al. JCHF 2013;1:

Toray microarray analysis of the four groups of patients (A) and in patients with calcium score >100 (B). Toray microarray analysis of the four groups.

Gene ontology (GO) term enrichment for significantly downregulated genes. Gene ontology (GO) term enrichment for significantly downregulated genes. Visualization.

Anna Björkenheim et al. JACEP 2017;j.jacep

Nat. Rev. Cardiol. doi: /nrcardio

Maria Rosa Costanzo et al. JCHF 2016;4:95-105

HRs of NAFLD with or without obesity for incident gastric cancer and colorectal cancer. HRs of NAFLD with or without obesity for incident gastric cancer.

(A) Absolute and (B) change from baseline in 6 min walk distance over time for all patients and by Down syndrome status. (A) Absolute and (B) change from.

Tukey boxplots overlaid on data points from objective and subjective measures, displaying results from study 1. Tukey boxplots overlaid on data points.

Differential expression of TRM markers by donor- and recipient-derived T cells with time. Differential expression of TRM markers by donor- and recipient-derived.

Comparisons of “even” mock communities (a) and “staggered” mock communities (b) sequenced by MiSeqPE300 and HiSeqPE250. Comparisons of “even” mock communities.

Figure 4. The N:M ratio is significantly increased in patients with ALS and correlates with disease progression The N:M ratio is significantly increased.

The amplitude of oscillation of end-tidal CO2 correlates to the amplitude of oscillation of cardiac output for both patients with heart failure (no fill)

(A) Absolute and B) change from baseline in 6 min walk distance over time for patients on bosentan monotherapy by Down syndrome status. (A) Absolute and.

The 6MWT results showing improvement from baseline at 1, 6 and 12 months in patients receiving an implant (mean±SE of mean). The 6MWT results showing improvement.

Relationship between FFM, daily EI and daily profile of hunger.

The Bov-A2 element is conserved in the NOS2 gene of bovid species.

Khadijah Breathett et al. JCHF 2017;5:

Figure 3. Temporal trends in individual serum lipid fractions in ICH patients by APOE allele carrier status Temporal trends in individual serum lipid fractions.

Jeffrey J. Teuteberg et al. JCHF 2015;3:

Kaplan-Meier survival estimates for major cardiovascular events.

William T. Abraham et al. JCHF 2018;j.jchf

Morphology of the four L1 IN populations.

Effect of RO and placebo on IOP

Khadijah Breathett et al. JCHF 2017;5:

Effects of paclitaxel and vinblastine.

Dennis M. McNamara et al. JCHF 2014;2:

Orly Vardeny et al. JCHF 2016;4:

Maria R. Costanzo et al. JCHF 2016;4:

Nail photographs and MRI scans of a patient with psoriatic arthritis.

Changes of visual acuity (VA) at baseline, at 3 and 6 months before, and at 3, 6 and 12 months after the initiation of the administration of sodium–glucose.

Expression of 20 genes significantly associated with reduced survivability in GBM is shown across 33 TCGA diseases. Expression of 20 genes significantly.

Molecular definitions of lung adenocarcinoma subtypes.

WOMAC (Western Ontario and McMaster Universities Arthritis Index) symptoms in the operated knee and contralateral knee over time and by treatment. WOMAC.

Kaplan-Meier curve of the primary outcome in patients prescribed ACE inhibitor (ACEI) and angiotensin receptor blocker (ARB). Kaplan-Meier curve of the.

Kaplan-Meier curves showing the probability of symptom-free survival according to the rate of heart rate rise during exercise testing in (A) for the whole.

Medication intensity (ALLP) changes between baseline and 6 months, by (not) being low-density lipoprotein-cholesterol (LDL-C) target at baseline for nurse-coordinated.

Presentation transcript:

John P. Boehmer et al. JCHF 2017;5:216-225 Temporal Profile of HeartLogic Index Trends in Patients With and Without Heart Failure Events Data are displayed as mean ± SEM. The shaded regions represent the SEM. HeartLogic index in patients with usable HFE (blue line) aligned by the date of the HFE (vertical line) at Day 0; HeartLogic index in patients without HFE (black line) aligned by the last available HeartLogic index date for each patient (Day 30). Days related to heart failure events (HFEs) with the HeartLogic index are significantly greater (p < 0.05, rank sum test) than a 3-month baseline period ending 90 days before the HFE are indicated by asterisks. John P. Boehmer et al. JCHF 2017;5:216-225 2017 The Authors